Omeros Corporation (OMER)
NASDAQ: OMER · Real-Time Price · USD
9.18
-0.43 (-4.47%)
Feb 21, 2025, 4:00 PM EST - Market closed
Omeros Employees
Omeros had 198 employees as of December 31, 2023. The number of employees increased by 2 or 1.02% compared to the previous year.
Employees
198
Change (1Y)
2
Growth (1Y)
1.02%
Revenue / Employee
n/a
Profits / Employee
-$679,419
Market Cap
531.98M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
OMER News
- 2 days ago - Omeros Announces Robust Results for Narsoplimab Expanded Access Program in TA-TMA - Business Wire
- 8 days ago - Omeros Corporation Announces Availability on its Website of Materials Accompanying Narsoplimab Presentations at the 2025 Tandem Meetings - Business Wire
- 12 days ago - Omeros Corporation Announces Upcoming Presentations Detailing Outcomes of Narsoplimab Treatment for TA-TMA Under an Expanded Access Program - Business Wire
- 5 weeks ago - Omeros Announces Update on Statistical Analysis of Narsoplimab Pivotal Trial Primary Endpoint - Business Wire
- 2 months ago - Omeros Antibody Improves Overall Survival In Rare Complication After Stem Cell Transplant, Stock Surges - Benzinga
- 2 months ago - Omeros' Narsoplimab Meets its Pivotal Trial Primary Endpoint – Statistical Analysis Shows Survival Superiority Over External Control in Patients with TA-TMA - Business Wire
- 2 months ago - Omeros Corporation Announces Presentation of Positive Zaltenibart Data at ASH Annual Meeting - Business Wire
- 2 months ago - Omeros Corporation Announces Upcoming Presentations at ASH Annual Meeting - Business Wire